Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Damaschke

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Epigenetics|August 27, 2013
Pyrosequencing for the rapid and efficient quantification of allele-specific expressionBing Yang, Jennifer Wagner, Tianyu Yao, et al.
Journal of Cellular Biochemistry|January 13, 2015
Pyrosequencing for accurate imprinted allele expression analysisBing Yang, Nathan Damaschke, Tianyu Yao, et al.
Plos One|April 16, 2015
Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrenceJennifer Wagner, Nathan Damaschke, Bing Yang, et al.
BMC Cancer|December 22, 2017
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomesShivashankar Damodaran, Nathan Damaschke, Joseph Gawdzik, et al.
Plos One|February 22, 2014
A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activationBing Yang, Jennifer Wagner, Nathan Damaschke, et al.
ACS Chemical Biology|September 27, 2017
Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer DevelopmentJin-Hee Lee, Bing Yang, Anastasia J Lindahl, et al.
Plos One|February 25, 2017
Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapyMichael L Blute, Nathan Damaschke, Jennifer Wagner, et al.
Clinical Epigenetics|November 30, 2019
Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsiesBing Yang, Tyler Etheridge, Johnathon McCormick, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Epigenetics|August 27, 2013
Pyrosequencing for the rapid and efficient quantification of allele-specific expressionBing Yang, Jennifer Wagner, Tianyu Yao, et al.
Journal of Cellular Biochemistry|January 13, 2015
Pyrosequencing for accurate imprinted allele expression analysisBing Yang, Nathan Damaschke, Tianyu Yao, et al.
Plos One|April 16, 2015
Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrenceJennifer Wagner, Nathan Damaschke, Bing Yang, et al.
BMC Cancer|December 22, 2017
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomesShivashankar Damodaran, Nathan Damaschke, Joseph Gawdzik, et al.
Plos One|February 22, 2014
A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activationBing Yang, Jennifer Wagner, Nathan Damaschke, et al.
ACS Chemical Biology|September 27, 2017
Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer DevelopmentJin-Hee Lee, Bing Yang, Anastasia J Lindahl, et al.
Plos One|February 25, 2017
Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapyMichael L Blute, Nathan Damaschke, Jennifer Wagner, et al.
Clinical Epigenetics|November 30, 2019
Validation of an epigenetic field of susceptibility to detect significant prostate cancer from non-tumor biopsiesBing Yang, Tyler Etheridge, Johnathon McCormick, et al.
Pageof 1